05/20/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/20/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the COVID-19 Airway Management Isolation Chamber. This device is authorized for use by healthcare providers (HCP) as an extra layer of barrier protection in addition to personal protective equipment (PPE) to prevent HCP exposure to pathogenic biological airborne particulates during transport of patients, at the time of definitive airway management, or when performing medical procedures on such patients during the COVID-19 pandemic. (PDF)
05/20/2020 12:00 AM EDT
Source: U.S. Government Accountability Office (GAO). Published: 5/20/2020. This 15-page report discusses findings that, prior to the COVID-19 pandemic, most nursing homes were cited for infection prevention and control deficiencies (82 percent of those surveyed from 2013-2017). About half of these homes had persistent problems and were cited across multiple years. (PDF)
05/20/2020 12:00 AM EDT
Source: U.S. Government Accountability Office (GAO). Published: 5/20/2020. This two-page Spotlight looks at the three types of FDA-authorized COVID-19 tests. Molecular and antigen tests help diagnose active infections. Molecular tests look for the virus’s genetic material, while antigen tests look for unique parts of the virus. Results can be used for quarantines, routing supplies, and other uses. Serology tests look for antibodies in the blood to help determine prior exposure. (PDF)
05/20/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/20/2020. This guidance is intended to inform healthcare providers about the diagnosis, evaluation, infection prevention and control practices, and disposition of neonates (≤28 days old) with confirmed or suspected COVID-19 or known COVID-19 exposure, including birth to a mother with confirmed or suspected COVID-19. (Text)
05/20/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/20/2020. The Centers for Disease Control and Prevention and the Office of the Assistant Secretary for Preparedness and Response have developed these five COVID-19 Pandemic Planning Scenarios that are designed to help inform decisions by modelers and public health officials who utilize mathematical modeling. The planning scenarios are being used by mathematical modelers throughout the federal government. (Text)
05/20/2020 12:00 AM EDT
Source: Northwest Center for Public Health Practice [University of Washington] (NWCPHP). Published: 5/20/2020. This course was designed to help public health agencies expand their contact tracing efforts and slow the spread of COVID-19. Public health professionals, who might not have experience with contact tracing, can take this course to learn the basics and to be successful in reaching out to community members to save lives. (Video or Multimedia)
05/20/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/20/2020. This web page, updated on May 20, 2020, provides a table of COVID-19 sequences that are intended to be used for the purposes of respiratory virus surveillance and research. (Text)
05/18/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/18/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Lyra Direct SARS-CoV-2 Assay, which received an Emergency Use Authorization from the Food and Drug Administration on May 18, 2020. The Lyra Direct SARS-CoV-2 Assay is authorized for use on respiratory specimens from individuals suspected of COVID-19 by their healthcare provider. (PDF)
05/18/2020 12:00 AM EDT
Source: Centers for Medicare & Medicaid Services (CMS). Published: 5/18/2020. This 10-page document provides recommendations to help determine the level of mitigation needed to prevent the transmission of COVID-19 in nursing homes. The recommendations cover these topics: Criteria for relaxing certain restrictions and mitigating the risk of resurgence: Factors to inform decisions for relaxing nursing home restrictions through a phased approach; Visitation and service considerations: Considerations allowing visitation and services in each phase; and Restoration of survey activities: Recommendations for restarting certain surveys in each phase. (PDF)
05/17/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/17/2020. This web page describes how to get the CDC 2019 Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel and supplies. The panel detects the SARS-CoV-2 virus in upper and lower respiratory specimens. It is designed to be used with an existing RT-PCR testing instrument commonly used to test for seasonal influenza. (Text)
05/14/2020 12:00 AM EDT
Source: ADA [Americans with Disabilities Act] National Network. Published: 5/14/2020. This one-hour, 25-minute webinar focuses on the 2019 California Public Safety Power Shut-offs (PSPS), including stories from the community, barriers experienced, coordination across public and private agencies, and effective strategies that could become best practices. Speakers discuss how the California Foundation for Independent Living Centers (CFILC) and Independent Living Centers (ILC) are partnering with other stakeholders across the state to support people with disabilities and older adults during different types of disasters. (Video or Multimedia)
05/04/2020 12:00 AM EDT
Source: International Committee of the Red Cross (ICRC). Published: 5/4/2020. This four-page checklist has been produced for managers of healthcare services, individual practitioners, and health policymakers worried about the impact of violence against healthcare workers, facilities, and patients during the COVID-19 response. It provides a practical, actionable summary of important measures for preventing, reducing, and mitigating the effects of violence against healthcare workers and patients during the COVID-19 response. It also contains a series of online references to help understand and implement these measures. (PDF)
05/01/2020 12:00 AM EDT
Source: Minnesota Department of Health. Published: 5/2020. This app, developed with the University of Minnesota, aids those deployed to emergency response events in maintaining their own physical, emotional, and social well-being. It was refined in early 2020 as a modified/simplified tool for team members engaged in responding to the COVID-19 epidemic. (Video or Multimedia)
04/27/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/27/2020. This web page provides COVID-19 Modules for Reporting in Acute Care, Long Term Acute Care, Inpatient Rehabilitation, Inpatient Psychiatric, and Long Term Care facilities, including nursing homes. Each module enables hospitals to report daily counts of patients with suspected or confirmed COVID-19 diagnoses and current use and availability of hospital beds and mechanical ventilators, as well as both healthcare worker staffing and supply status and availability. (Video or Multimedia)
04/01/2020 12:00 AM EDT
Source: National Association of County and City Health Officials (NACCHO). Published: 4/2020. This two-page document summarizes the findings of the 2019 Healthcare-Associated Infections and Antibiotic Resistance Assessment. It highlights the extent to which local health departments (LHDs) engage in healthcare-associated infection and antibiotic resistance activities, existing LHD partner engagement, the role that LHDs play in outbreak response, and LHD capacity and infrastructure in healthcare-associated infection and antibiotic resistance prevention and control. (PDF)
03/12/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 3/12/2020. This two-page leaflet provides basic information on novel coronavirus disease (COVID-19), how it spreads, symptoms, how to avoid catching or spreading the virus, and some specific advice for people with immunocompromising condition, their families, and care-givers. (PDF)
.png)
No hay comentarios:
Publicar un comentario